Your browser doesn't support javascript.
loading
Therapeutics, Placebo, and the Importance of Hard Outcomes in Irritable Bowel Syndrome Research.
Glissen Brown, Jeremy R; Lembo, Anthony J.
Affiliation
  • Glissen Brown JR; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Lembo AJ; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Clin Gastroenterol Hepatol ; 20(5): e921-e922, 2022 05.
Article in En | MEDLINE | ID: mdl-34752965
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Irritable Bowel Syndrome Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Irritable Bowel Syndrome Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Country of publication: United States